\-\ Texto\\:\\ \ \(0\)\
\-\ alert\\ and\\ oriented\\ x3\\,\\ communicative\\.\\ no\\ jvd\\.\\ bibasilar\\ crackles\\ in\\ chest\\.\\ tachycardic\\ with\\ irregularly\\ irregular\\ rhythm\\.\\ no\\ rubs\\/murmurs\\.\\ soft\\,\\ nontender\\,\\ normoactive\\ bs\\,\\ no\\ organomegaly\\.\\ pulses\\ 2\\+\\/palpable\\.\\ tender\\ right\\ upper\\ extremity\\ with\\ edema\\ and\\ slight\\ erythema\\.\ \(0\)\
\-\ since\\ the\\ patient\\ was\\ already\\ started\\ on\\ lovenox\\ for\\ thrombotic\\ prophylaxis\\,\\ oral\\ coumadin\\ once\\ a\\ day\\ was\\ added\\ to\\ medication\\ list\\ for\\ 4\\-5\\ days\\ until\\ she\\ reaches\\ therapeutic\\ inr\\ levels\\.\ \(0\)\
\-\ compression\\ ultrasonography\\ with\\ color\\ duplex\\ imaging\\ of\\ right\\ upper\\ extremity\\ showed\\ two\\ brachial\\ veins\\ accompanying\\ the\\ brachial\\ artery\\.\\ at\\ the\\ point\\ of\\ distal\\ brachial\\ artery\\,\\ the\\ right\\ brachial\\ vein\\ is\\ noted\\ to\\ have\\ a\\ lumen\\ with\\ variable\\ echogenicity\\.\\ compression\\ view\\ at\\ the\\ distal\\ brachial\\ veins\\ shows\\ incomplete\\ collapse\\ of\\ the\\ apposing\\ walls\\ of\\ the\\ right\\ brachial\\ vein\\.\\ color\\-flow\\ of\\ the\\ right\\ brachial\\ vein\\ shows\\ a\\ partial\\ filling\\ defect\\ on\\ longitudinal\\ view\\ and\\ non\\-filling\\ color\\ flow\\ on\\ transverse\\ view\\.\\ compression\\ and\\ color\\ flow\\ views\\ of\\ the\\ right\\ internal\\ jugular\\,\\ axillary\\,\\ cephalic\\,\\ basilic\\,\\ and\\ proximal\\ brachial\\ veins\\ showed\\ low\\ echogenicity\\,\\ compressible\\ walls\\,\\ and\\ normal\\ flow\\.\ \(0\)\
\-\ upper\\ extremity\\ dvt\ \(0\)\
\-\ \\*\\ upper\\ extremity\\ dvt\ \(0\)\
\-\ \\*\\ thrombophlebitis\ \(0\)\
\-\ \\*\\ cellulitis\ \(0\)\
\-\ \\*\\ lymphangitis\\,\\ lymph\\ obstruction\\ \ \(0\)\
\-\ \\*\\ venous\\ insufficiency\ \(0\)\
\-\ 82\\ yo\\ female\\ with\\ history\\ significant\\ for\\ htn\\ and\\ hypothyroidism\\ was\\ admitted\\ to\\ wramc\\ for\\ one\\ day\\ of\\ dyspnea\\ associated\\ with\\ exertion\\.\\ it\\ was\\ exacerbated\\ by\\ movement\\ and\\ alleviated\\ with\\ rest\\.\\ patient\\ denied\\ chest\\ pain\\/jaw\\-arm\\ numbness\\/diaphoresis\\/loc\\.\\ she\\ was\\ admitted\\ for\\ atrial\\ fibrillation\\ with\\ right\\ ventricular\\ hypertrophy\\.\\ rate\\ was\\ controlled\\ with\\ metoprolol\\ and\\ iv\\ labetalol\\.\\ she\\ was\\ also\\ given\\ lovenox\\ once\\ daily\\ for\\ thrombotic\\ prophylaxis\\.\\ however\\,\\ during\\ hospital\\ day\\ 5\\,\\ patient\\ was\\ found\\ to\\ have\\ edema\\ in\\ her\\ right\\ upper\\ extremity\\.\ \(0\)\
\-\ this\\ patient\\ had\\ some\\ of\\ the\\ major\\ risk\\ factors\\ that\\ increase\\ the\\ probability\\ of\\ having\\ a\\ dvt\\:\\ she\\ was\\ over\\ the\\ age\\ of\\ 75\\ years\\ and\\ required\\ intravascular\\ access\\ in\\ order\\ to\\ receive\\ a\\ rate\\ controlling\\ medication\\.\\ normally\\,\\ a\\ person\\ with\\ a\\ known\\ reversible\\ cause\\ of\\ dvt\\ can\\ stop\\ coumadin\\ after\\ at\\ least\\ three\\ months\\ of\\ treatment\\.\\ although\\ there\\ was\\ an\\ obvious\\ and\\ reversible\\ cause\\ for\\ her\\ right\\ upper\\ extremity\\ dvt\\,\\ the\\ patient\\ was\\ also\\ newly\\ diagnosed\\ with\\ atrial\\ fibrillation\\.\\ her\\ treatment\\ with\\ coumadin\\ should\\ continue\\ and\\ maintain\\ inr\\ levels\\ between\\ 2\\-3\\ in\\ order\\ to\\ prevent\\ future\\ thrombus\\ formation\\.\\ however\\,\\ if\\ she\\ has\\ an\\ increased\\ risk\\ of\\ falls\\,\\ the\\ risk\\ of\\ suffering\\ a\\ fatal\\ cranial\\ bleed\\ becomes\\ greater\\ than\\ the\\ benefit\\ of\\ preventing\\ an\\ acute\\ thrombotic\\ event\\.\\ in\\ this\\ case\\,\\ removing\\ coumadin\\ after\\ three\\ months\\ of\\ treatment\\ would\\ be\\ reasonable\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ brachial\\:\\ 0\\.09600392236088148\ \(0\)\
\-\ dvt\\:\\ 0\\.05926796497226159\ \(0\)\
\-\ \\*\\:\\ 0\\.052368671953965634\ \(0\)\
\-\ coumadin\\:\\ 0\\.04770326909519245\ \(0\)\
\-\ extremity\\:\\ 0\\.04130166039175028\ \(0\)\
\-\ thrombotic\\:\\ 0\\.039931253535639095\ \(0\)\
\-\ color\\:\\ 0\\.027562516683866473\ \(0\)\
\-\ lovenox\\:\\ 0\\.02753554654848001\ \(0\)\
\-\ upper\\:\\ 0\\.02725216526919011\ \(0\)\
\-\ veins\\:\\ 0\\.027014078889344654\ \(0\)\
\-\ she\\:\\ 0\\.02641834957548648\ \(0\)\
\-\ reversible\\:\\ 0\\.025217955817657192\ \(0\)\
\-\ was\\:\\ 0\\.023945050097688447\ \(0\)\
\-\ fibrillation\\:\\ 0\\.023851634547596225\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.023567323881791946\ \(0\)\
\-\ inr\\:\\ 0\\.023567323881791946\ \(0\)\
\-\ view\\:\\ 0\\.021185330146133514\ \(0\)\
\-\ compression\\:\\ 0\\.021137096869823305\ \(0\)\
\-\ risk\\:\\ 0\\.020452907361403656\ \(0\)\
\-\ vein\\:\\ 0\\.020431277458243066\ \(0\)\
\-\ echogenicity\\:\\ 0\\.020246743254583224\ \(0\)\
\-\ communicative\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ rubs\\/murmurs\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ 2\\+\\/palpable\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ basilic\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ lymphangitis\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ pain\\/jaw\\-arm\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ numbness\\/diaphoresis\\/loc\\:\\ 0\\.019417441462481276\ \(0\)\
\-\ once\\:\\ 0\\.01926373201531358\ \(0\)\
\-\ atrial\\:\\ 0\\.01926373201531358\ \(0\)\
\-\ walls\\:\\ 0\\.019212207611070443\ \(0\)\
\-\ medication\\:\\ 0\\.018963255142949994\ \(0\)\
\-\ order\\:\\ 0\\.018867484276710318\ \(0\)\
\-\ flow\\:\\ 0\\.01866114896602544\ \(0\)\
\-\ day\\:\\ 0\\.017927047330525966\ \(0\)\
\-\ apposing\\:\\ 0\\.017890685558164216\ \(0\)\
\-\ non\\-filling\\:\\ 0\\.017890685558164216\ \(0\)\
\-\ labetalol\\:\\ 0\\.017890685558164216\ \(0\)\
\-\ right\\:\\ 0\\.017873756348003856\ \(0\)\
\-\ color\\-flow\\:\\ 0\\.016997590606384116\ \(0\)\
\-\ her\\:\\ 0\\.01697849113536301\ \(0\)\
\-\ admitted\\:\\ 0\\.016262354381335855\ \(0\)\
\-\ removing\\:\\ 0\\.01587242403421233\ \(0\)\
\-\ levels\\:\\ 0\\.01553855239326856\ \(0\)\
\-\ compressible\\:\\ 0\\.015470834702067057\ \(0\)\
\-\ alleviated\\:\\ 0\\.014837173749530095\ \(0\)\
\-\ metoprolol\\:\\ 0\\.014837173749530095\ \(0\)\
\-\ rate\\:\\ 0\\.014672781896369355\ \(0\)\
\-\ controlling\\:\\ 0\\.014577739750286959\ \(0\)\
\-\ cephalic\\:\\ 0\\.014135733813145658\ \(0\)\
\-\ wramc\\:\\ 0\\.014135733813145658\ \(0\)\
\-\ reaches\\:\\ 0\\.013944078797749997\ \(0\)\
\-\ suffering\\:\\ 0\\.013944078797749997\ \(0\)\
\-\ x3\\:\\ 0\\.013604539855399207\ \(0\)\
\-\ added\\:\\ 0\\.013310417845213033\ \(0\)\
\-\ normoactive\\:\\ 0\\.013176883435925733\ \(0\)\
\-\ probability\\:\\ 0\\.013176883435925733\ \(0\)\
\-\ jvd\\:\\ 0\\.012931893050220394\ \(0\)\
\-\ preventing\\:\\ 0\\.01281891222557821\ \(0\)\
\-\ cause\\:\\ 0\\.012736839764546107\ \(0\)\
\-\ intravascular\\:\\ 0\\.012711444903619109\ \(0\)\
\-\ fatal\\:\\ 0\\.012711444903619109\ \(0\)\
\-\ three\\:\\ 0\\.012689974574215465\ \(0\)\
\-\ thrombophlebitis\\:\\ 0\\.012608977908828596\ \(0\)\
\-\ 4\\-5\\:\\ 0\\.012511066537527201\ \(0\)\
\-\ duplex\\:\\ 0\\.012511066537527201\ \(0\)\
\-\ stop\\:\\ 0\\.012511066537527201\ \(0\)\
\-\ newly\\:\\ 0\\.012511066537527201\ \(0\)\
\-\ reasonable\\:\\ 0\\.012417322893432935\ \(0\)\
\-\ showed\\:\\ 0\\.012342745673672674\ \(0\)\
\-\ irregularly\\:\\ 0\\.012241017369922943\ \(0\)\
\-\ ultrasonography\\:\\ 0\\.012241017369922943\ \(0\)\
\-\ exacerbated\\:\\ 0\\.012241017369922943\ \(0\)\
\-\ bibasilar\\:\\ 0\\.0121578888941898\ \(0\)\
\-\ tachycardic\\:\\ 0\\.0121578888941898\ \(0\)\
\-\ person\\:\\ 0\\.0121578888941898\ \(0\)\
\-\ organomegaly\\:\\ 0\\.012000490295110185\ \(0\)\
\-\ access\\:\\ 0\\.011925817273798113\ \(0\)\
\-\ \\,\\:\\ 0\\.011925553547017066\ \(0\)\
\-\ bs\\:\\ 0\\.011853592994452319\ \(0\)\
\-\ accompanying\\:\\ 0\\.011853592994452319\ \(0\)\
\-\ list\\:\\ 0\\.011783661940895973\ \(0\)\
\-\ falls\\:\\ 0\\.011783661940895973\ \(0\)\
\-\ 82\\:\\ 0\\.011650127531608672\ \(0\)\
\-\ maintain\\:\\ 0\\.011524227941652839\ \(0\)\
\-\ treatment\\:\\ 0\\.011429186957715113\ \(0\)\
\-\ controlled\\:\\ 0\\.01129215632126115\ \(0\)\
\-\ for\\:\\ 0\\.011241755595812789\ \(0\)\
\-\ benefit\\:\\ 0\\.011237767306744913\ \(0\)\
\-\ artery\\:\\ 0\\.011209383225146252\ \(0\)\
\-\ already\\:\\ 0\\.011184688999302049\ \(0\)\
\-\ cellulitis\\:\\ 0\\.011184688999302049\ \(0\)\
\-\ receive\\:\\ 0\\.011082222004511536\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.011032722322018016\ \(0\)\
\-\ exertion\\:\\ 0\\.011032722322018016\ \(0\)\
\-\ crackles\\:\\ 0\\.010936940137128722\ \(0\)\
\-\ jugular\\:\\ 0\\.010800650701626327\ \(0\)\
\-\ bleed\\:\\ 0\\.010757032579828574\ \(0\)\
\-\ edema\\:\\ 0\\.010647240041547537\ \(0\)\
\-\ therapeutic\\:\\ 0\\.010590716384876712\ \(0\)\
\-\ however\\:\\ 0\\.01048179760174921\ \(0\)\
\-\ future\\:\\ 0\\.010436081453878369\ \(0\)\
\-\ event\\:\\ 0\\.010399061369481053\ \(0\)\
\-\ htn\\:\\ 0\\.010362653215403497\ \(0\)\
\-\ shows\\:\\ 0\\.010349663875457616\ \(0\)\
\-\ months\\:\\ 0\\.010281679712291046\ \(0\)\
\-\ distal\\:\\ 0\\.010234707440290867\ \(0\)\
\-\ axillary\\:\\ 0\\.010222755845971059\ \(0\)\
\-\ incomplete\\:\\ 0\\.010156003974835976\ \(0\)\
\-\ continue\\:\\ 0\\.010156003974835976\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.010156003974835976\ \(0\)\
\-\ variable\\:\\ 0\\.010028278737720667\ \(0\)\
\-\ insufficiency\\:\\ 0\\.009997472037335779\ \(0\)\
\-\ longitudinal\\:\\ 0\\.009849588110380648\ \(0\)\
\-\ becomes\\:\\ 0\\.009849588110380648\ \(0\)\
\-\ rhythm\\:\\ 0\\.009765400416944089\ \(0\)\
\-\ pulses\\:\\ 0\\.009738038038092643\ \(0\)\
\-\ daily\\:\\ 0\\.009738038038092643\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.009684312370418283\ \(0\)\
\-\ nontender\\:\\ 0\\.009657933094984987\ \(0\)\
\-\ collapse\\:\\ 0\\.00963186600765679\ \(0\)\
\-\ 75\\:\\ 0\\.00963186600765679\ \(0\)\
\-\ obvious\\:\\ 0\\.009505966417700955\ \(0\)\
\-\ thrombus\\:\\ 0\\.009505966417700955\ \(0\)\
\-\ patient\\:\\ 0\\.009433831838286211\ \(0\)\
\-\ least\\:\\ 0\\.009433742138355159\ \(0\)\
\-\ movement\\:\\ 0\\.009410184232811663\ \(0\)\
\-\ alert\\:\\ 0\\.00938687562195145\ \(0\)\
\-\ prevent\\:\\ 0\\.009340985562694087\ \(0\)\
\-\ normally\\:\\ 0\\.009273894797309267\ \(0\)\
\-\ erythema\\:\\ 0\\.009251977768998323\ \(0\)\
\-\ oriented\\:\\ 0\\.009230276675511514\ \(0\)\
\-\ denied\\:\\ 0\\.009166427475350167\ \(0\)\
\-\ lumen\\:\\ 0\\.009063960480559652\ \(0\)\
\-\ chest\\:\\ 0\\.009007616740341493\ \(0\)\
\-\ dyspnea\\:\\ 0\\.008909325549561307\ \(0\)\
\-\ slight\\:\\ 0\\.008854026163810038\ \(0\)\
\-\ major\\:\\ 0\\.008800081185818197\ \(0\)\
\-\ rest\\:\\ 0\\.008679121367324552\ \(0\)\
\-\ having\\:\\ 0\\.008645747347455386\ \(0\)\
\-\ factors\\:\\ 0\\.008455472866841243\ \(0\)\
\-\ ventricular\\:\\ 0\\.008410365969608775\ \(0\)\
\-\ started\\:\\ 0\\.008395533299605814\ \(0\)\
\-\ until\\:\\ 0\\.008266351081364608\ \(0\)\
\-\ point\\:\\ 0\\.008224920834762194\ \(0\)\
\-\ cranial\\:\\ 0\\.008184255498110794\ \(0\)\
\-\ have\\:\\ 0\\.008151709596321992\ \(0\)\
\-\ oral\\:\\ 0\\.00793079882457602\ \(0\)\
\-\ increase\\:\\ 0\\.007895175786590113\ \(0\)\
\-\ an\\:\\ 0\\.007808358134040065\ \(0\)\
\-\ after\\:\\ 0\\.007788551553344505\ \(0\)\
\-\ formation\\:\\ 0\\.00776927619663428\ \(0\)\
\-\ views\\:\\ 0\\.00775817973401323\ \(0\)\
\-\ at\\:\\ 0\\.00765041730946013\ \(0\)\
\-\ tender\\:\\ 0\\.007639671571033105\ \(0\)\
\-\ lymph\\:\\ 0\\.007598111032917724\ \(0\)\
\-\ filling\\:\\ 0\\.007577621181238619\ \(0\)\
\-\ transverse\\:\\ 0\\.007547239414427307\ \(0\)\
\-\ partial\\:\\ 0\\.007527215247684462\ \(0\)\
\-\ irregular\\:\\ 0\\.007507371481291585\ \(0\)\
\-\ also\\:\\ 0\\.007421231690176879\ \(0\)\
\-\ hospital\\:\\ 0\\.007086115561603796\ \(0\)\
\-\ greater\\:\\ 0\\.007069859818657492\ \(0\)\
\-\ defect\\:\\ 0\\.007045698956607768\ \(0\)\
\-\ a\\:\\ 0\\.006988542763323371\ \(0\)\
\-\ diagnosed\\:\\ 0\\.006921134706596929\ \(0\)\
\-\ since\\:\\ 0\\.0069135784618903455\ \(0\)\
\-\ iv\\:\\ 0\\.0068687773952887535\ \(0\)\
\-\ venous\\:\\ 0\\.006832126912901166\ \(0\)\
\-\ required\\:\\ 0\\.006774725796888247\ \(0\)\
\-\ would\\:\\ 0\\.006698164930445132\ \(0\)\
\-\ obstruction\\:\\ 0\\.006637445040945894\ \(0\)\
\-\ given\\:\\ 0\\.006452454609066834\ \(0\)\
\-\ although\\:\\ 0\\.006356672424177542\ \(0\)\
\-\ internal\\:\\ 0\\.006310299276164695\ \(0\)\
\-\ should\\:\\ 0\\.006000459343367402\ \(0\)\
\-\ between\\:\\ 0\\.005965849198731815\ \(0\)\
\-\ known\\:\\ 0\\.005956059657409295\ \(0\)\
\-\ found\\:\\ 0\\.005931774481172054\ \(0\)\
\-\ days\\:\\ 0\\.005768886114916251\ \(0\)\
\-\ during\\:\\ 0\\.0057599322685546435\ \(0\)\
\-\ age\\:\\ 0\\.005728877369040323\ \(0\)\
\-\ some\\:\\ 0\\.005715700999706519\ \(0\)\
\-\ no\\:\\ 0\\.005685754299804859\ \(0\)\
\-\ yo\\:\\ 0\\.005663769875116216\ \(0\)\
\-\ proximal\\:\\ 0\\.005650976171160827\ \(0\)\
\-\ to\\:\\ 0\\.005644071917748717\ \(0\)\
\-\ years\\:\\ 0\\.005526967262155248\ \(0\)\
\-\ 5\\:\\ 0\\.00550696128291666\ \(0\)\
\-\ two\\:\\ 0\\.005390597439682832\ \(0\)\
\-\ low\\:\\ 0\\.005233850336710132\ \(0\)\
\-\ if\\:\\ 0\\.005107364391587303\ \(0\)\
\-\ one\\:\\ 0\\.005100729919186441\ \(0\)\
\-\ significant\\:\\ 0\\.00506133733712384\ \(0\)\
\-\ than\\:\\ 0\\.004931825671626155\ \(0\)\
\-\ over\\:\\ 0\\.004792164295462473\ \(0\)\
\-\ on\\:\\ 0\\.004783420786555692\ \(0\)\
\-\ and\\:\\ 0\\.004757947288076258\ \(0\)\
\-\ acute\\:\\ 0\\.0046473112975914\ \(0\)\
\-\ in\\:\\ 0\\.004640938657932323\ \(0\)\
\-\ increased\\:\\ 0\\.004604592030395717\ \(0\)\
\-\ soft\\:\\ 0\\.004583539127739097\ \(0\)\
\-\ the\\:\\ 0\\.0045677076443929225\ \(0\)\
\-\ noted\\:\\ 0\\.004461280150776638\ \(0\)\
\-\ associated\\:\\ 0\\.004441547493188771\ \(0\)\
\-\ imaging\\:\\ 0\\.004409854238888993\ \(0\)\
\-\ can\\:\\ 0\\.004269212230108083\ \(0\)\
\-\ this\\:\\ 0\\.004234084640150366\ \(0\)\
\-\ it\\:\\ 0\\.004230943578266557\ \(0\)\
\-\ case\\:\\ 0\\.004117851173716456\ \(0\)\
\-\ of\\:\\ 0\\.004105860821074482\ \(0\)\
\-\ had\\:\\ 0\\.004061343214186583\ \(0\)\
\-\ female\\:\\ 0\\.0038695160164049203\ \(0\)\
\-\ has\\:\\ 0\\.0035345814328067797\ \(0\)\
\-\ that\\:\\ 0\\.0032510588734775848\ \(0\)\
\-\ by\\:\\ 0\\.0031340768793939977\ \(0\)\
\-\ with\\:\\ 0\\.003092621394446425\ \(0\)\
\-\ normal\\:\\ 0\\.0029506882259892095\ \(0\)\
\-\ be\\:\\ 0\\.0029025478487751744\ \(0\)\
\-\ there\\:\\ 0\\.002801135586927288\ \(0\)\
\-\ history\\:\\ 0\\.00259959149274688\ \(0\)\
\-\ \\:\\:\\ 0\\.002489592105706311\ \(0\)\
\-\ \\.\\:\\ 0\\.002111205891251871\ \(0\)\
\-\ is\\:\\ 0\\.001238525943578691\ \(0\)\
